Prosecution Insights
Last updated: August 08, 2026

BIOASTER

8 pending office actions • 4 art units • 6 examiners • 0 of 8 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Portfolio Summary

8
Total Pending OAs
3
Non-Final OAs
5
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

7
Hard (88%)
1
Medium (12%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other5 (62%)
Double-patenting + other1 (12%)
Multi-statute (no §101)2 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

8
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

80 h
Manual time on pending OAs
16 h
Time saved (low, 20%)
28 h
Time saved (mid, 35%)
0.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KIM, YOUNG J 2 64.8% +18.0%
MYERS, CARLA J 2 48.9% +46.7%
KINSEY WHITE, NICOLE ERIN 1 58.0% +16.2%
SWITZER, JULIET CAROLINE 1 42.3% +53.8%
HAMMELL, NEIL P 1 34.6% +43.0%
GAO, ASHLEY HARTMAN 1 57.5% +42.4%

Hard Cases (7)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18580232 USE OF TORQUE TENO VIRUS (TTV) AS A MARKER TO DETERMINE THE RISK OF COMPLICATIONS IN A PATIENT ADMITTED TO A HEALTHCARE FACILITY KIM, YOUNG J 14d
18014885 METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT SWITZER, JULIET CAROLINE
18014878 METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT KIM, YOUNG J
18014814 METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT MYERS, CARLA J
18014801 METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT MYERS, CARLA J
17764323 METHOD FOR DETERMINING THE RISK OF OCCURRENCE OF A HEALTHCARE-ASSOCIATED INFECTION IN A PATIENT HAMMELL, NEIL P
17294327 METHODS AND REAGENTS FOR MULTIPLEX BINDING EXPERIMENTS GAO, ASHLEY HARTMAN

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18580232 USE OF TORQUE TENO VIRUS (TTV) AS A MARKER TO DETERMINE THE RISK OF COMPLICATIONS IN A PATIENT ADMITTED TO A HEALTHCARE FACILITY KIM, YOUNG J 14d
18014934 METHOD FOR DETERMINING THE RISK OF COMPLICATION IN A PATIENT KINSEY WHITE, NICOLE ERIN
18014885 METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT SWITZER, JULIET CAROLINE
18014878 METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT KIM, YOUNG J
18014814 METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT MYERS, CARLA J
18014801 METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT MYERS, CARLA J
17764323 METHOD FOR DETERMINING THE RISK OF OCCURRENCE OF A HEALTHCARE-ASSOCIATED INFECTION IN A PATIENT HAMMELL, NEIL P
17294327 METHODS AND REAGENTS FOR MULTIPLEX BINDING EXPERIMENTS GAO, ASHLEY HARTMAN

Top Art Units

Art UnitApps
1681 3
1682 3
1672 1
1678 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18580232 USE OF TORQUE TENO VIRUS (TTV) AS A MARKER TO DETERMINE THE RISK OF COMPLICATIONS IN A PATIENT ADMITTED TO A HEALTHCARE FACILITY KIM, YOUNG J 1681 §101§103§112 Non-Final OA 14d Pending Jan 18, 2024
18014934 METHOD FOR DETERMINING THE RISK OF COMPLICATION IN A PATIENT KINSEY WHITE, NICOLE ERIN 1672 §103§112DP Final Rejection Pending Jan 06, 2023
18014885 METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT SWITZER, JULIET CAROLINE 1682 §101§103§112DPOther Final Rejection Pending Jan 06, 2023
18014878 METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT KIM, YOUNG J 1681 §103§112 Final Rejection Pending Jan 06, 2023
18014814 METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT MYERS, CARLA J 1682 §101§102§112Other Non-Final OA Pending Jan 06, 2023
18014801 METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-RELATED INFECTION IN A PATIENT MYERS, CARLA J 1682 §101§102§112Other Non-Final OA Pending Jan 06, 2023
17764323 METHOD FOR DETERMINING THE RISK OF OCCURRENCE OF A HEALTHCARE-ASSOCIATED INFECTION IN A PATIENT HAMMELL, NEIL P 1681 §101§112 Final Rejection Pending Mar 28, 2022
17294327 METHODS AND REAGENTS FOR MULTIPLEX BINDING EXPERIMENTS GAO, ASHLEY HARTMAN 1678 §103§112 Final Rejection Pending May 14, 2021

Managing BIOASTER's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month